{
    "code": "01049344",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01049344",
    "time": "2023-05-18 19:32:21",
    "許可證字號": "衛署藥製字第049344號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/03\/26",
    "發證\/登錄日期": "97\/03\/26",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00104934402",
    "中文品名": "固栓宜膜衣錠 75 毫克",
    "英文品名": "Carvetone F.C. Tablets 75 mg",
    "適應症": "降低近期發生中風、心肌梗塞或周邊動脈血管疾病的粥狀動脈硬化病人之粥狀動脈硬化事件(如：心肌梗塞、中風或其他因血管病變引起的死亡)的發生。與aspirin併用降低非ST段上升之急性冠心病(不穩定性心絞痛和非Q波型心肌梗塞)病人。(包括經皮冠狀動脈介入性治療後放置支架的患者)之粥狀動脈栓塞事件。與Aspirin併用可用於以內科治療的ST段上升之急性心肌梗塞病人。",
    "劑型": "116膜衣錠",
    "包裝": "2~1000錠塑膠瓶裝 及鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CLOPIDOGREL HYDROGEN SULFATE",
    "限制項目": "01國　產 25監視中學名藥 61完成BE試驗",
    "申請商名稱": "中國化學製藥股份有限公司新豐工廠",
    "申請商地址": "新竹縣新豐鄉坑子口１８２之１號",
    "主製造廠": [
        {
            "製造廠名稱": "中國化學製藥股份有限公司新豐工廠",
            "製造廠廠址": "新竹縣新豐鄉坑子口182-1號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012600210",
            "成分名稱": "CLOPIDOGREL HYDROGEN SULFATE",
            "含量描述": "(eq. to Clopidogrel 75mg)",
            "含量": "97.8750000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "衛署藥製字第049344號_75mg_藥物外觀-108-06-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛署藥製字第049344號-仿單-109-03-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=010&Type=9"
        },
        {
            "title": "01049344-106-11-22.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=009&Type=9"
        },
        {
            "title": "Carvetone FCT In-106-06-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=008&Type=9"
        },
        {
            "title": "A049344 In-104-11-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=007&Type=9"
        },
        {
            "title": "衛署藥製字第049344號_75mg_外盒-108-06-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=010&Type=8"
        },
        {
            "title": "Carvetone F.C. Tablets 75 mg Box-106-06-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=009&Type=8"
        },
        {
            "title": "Carvetone La-106-06-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=008&Type=8"
        },
        {
            "title": "Carvetone La-104-11-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01049344&Seq=007&Type=8"
        }
    ]
}